Table 5.
Multivariate analysis of factors significantly associated with severe and symptomatic HYPOs
(95% CI) | RR | |
---|---|---|
Factors associated with severe hypoglycemia (SeH) | ||
Diameter ≥ 4 cm | 2.24–5.37 | 3.38 |
Abdominal site | 1.55–2.88 | 2.04 |
LH at the abdominal site | 1.86–2.91 | 2.38 |
LHs at multiple sites | 2.68–4.79 | 3.95 |
Needle reuse | 2.22–3.87 | 3.46 |
Failure to rotate injection sites | 2.89–4.90 | 3.67 |
Insulin dose > 40 units/day | 1.15–2.19 | 1.68 |
Ice-cold insulin | 2.75–4.88 | 3.39 |
Factors associated with symptomatic hypoglycemia (SyH) | ||
LH at the abdominal site | 1.22–2.63 | 2.17 |
LHs at multiple sites | 1.85–2.78 | 2.39 |
Injection into LH nodules | 2.59–5.98 | 4.21 |
Needle reuse | 2.25–6.65 | 4.74 |
Failure to rotate injection sites | 2.48–4.56 | 3.49 |
Insulin dose > 40 units/day | 1.93–2–21 | 1.48 |
Post-injection drop-leaking | 0.98–1.88 | 1.21 |
Ice-cold insulin | 2.06–3.98 | 2.58 |